Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, ...

Discover why Hims & Hers is leading the telehealth market with strong growth, a loyal user base, and expansion into new ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy Zepbound in an expansion of the ways patients with a prescription can access the drug. The agreement means Ro has ...

Telehealth companies rushed to sell cheaper copycats when the branded drugs, such as Lilly's Zepbound and Novo's Wegovy ... medispas to cease production and sales of the copycats.

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S. drugs regulator clamps down on mass production of copies of the in-demand ...

Getty Images' landmark copyright lawsuit against artificial intelligence company Stability AI begins at London's High Court ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.